Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Cancer Prevention Research (Philadelphia, Pa.)|March 8, 2013
Early-phase development of cancer prevention agents: challenges and opportunitiesMarjorie Perloff, Vernon E SteeleFrontiers in Bioscience (Landmark Edition)|January 4, 2011
Triterpenoids as potential agents for the chemoprevention and therapy of breast cancerAnupam Bishayee, Shamima Ahmed, Nikoleta Brankov, et al.Expert Opinion on Investigational Drugs|October 31, 2003
Fenretinide: a prototype cancer prevention drugWinfred Malone, Marjorie Perloff, James Crowell, et al.Journal of the American College of Surgeons|August 10, 2002
Transforming growth factor-alpha: a surrogate endpoint biomarker?Samuel W Beenken, Richard Hockett, William Grizzle, et al.Oncotarget|April 17, 2017
Selenomethionine and methyl selenocysteine: multiple-dose pharmacokinetics in selenium-replete menJames R Marshall, Raymond F Burk, Rochelle Payne Ondracek, et al.Cancer Prevention Research (Philadelphia, Pa.)|August 19, 2010
Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer studyH-H Sherry Chow, Linda L Garland, Chiu-Hsieh Hsu, et al.Cancer Prevention Research (Philadelphia, Pa.)|December 16, 2015
Double-Blind, Randomized Trial of Alternative Letrozole Dosing Regimens in Postmenopausal Women with Increased Breast Cancer RiskAna Maria López, Sandhya Pruthi, Judy C Boughey, et al.Cancer Prevention Research (Philadelphia, Pa.)|August 18, 2011
Methyl selenocysteine: single-dose pharmacokinetics in menJames R Marshall, Clement Ip, Karen Romano, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinideAndrea Decensi, Umberto Veronesi, Rosalba Miceli, et al.Cancer Research|October 12, 2010
Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axisVictoria A Brown, Ketan R Patel, Maria Viskaduraki, et al.Pageof 3